InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Ruegg Curtis. Officer active across 1 company, notably Revance Therapeutics, Inc.. In total, 6 filings have been recorded. Breakdown: 0 buy · 2 sells. Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Ruegg Curtis is EVP, Technical Operations at Revance Therapeutics, Inc. He has 6 filings in total, and across the 6 sampled recent filings between 2016-01-08 and 2016-02-11, the most frequent transaction nature is option exercise.